第61回日本神経学会学術大会

セッション情報

ホットトピックス

[HT-03] ホットトピックス03
Dawn of new era: management of migraine headache

2020年8月31日(月) 13:30 〜 15:00 第01会場 (岡山コンベンションセンター 4F 405会議室)

座長:平田 幸一(獨協医科大学 脳神経内科),寺山 靖夫(湘南慶育病院 脳神経センター)

五十嵐 久佳 (富士通クリニック 内科(頭痛外来))

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

David W. Dodick (Mayo Clinic)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

柴田 護 (慶應義塾大学病院 神経内科)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

團野 大介 (富永病院 脳神経内科・頭痛センター)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

牛田 享宏, 厚生労働省慢性の痛み政策研究班 (愛知医科大学医学部学際的痛みセンター)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.